IB Neuro performs quantitative analysis of MRI dynamic susceptibility contrast (DSC) studies, a common perfusion MRI exam for evaluating brain tumors. Imaging Biometrics said that the software was included in the findings of a subcommittee on standardizing a DSC MRI protocol that was published in the journal Neuro-Oncology.

Imaging Biometrics believes that MRI-DSC imaging has been plagued by inconsistencies and suboptimal methods for acquiring and processing DSC-MRI scans. This results in mixed opinions regarding its usefulness. IB Neuro overcomes these limitations, according to the company.